Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Upfront Surgery vs Neoadjuvant Chemotherapy in Advanced Ovarian Cancer
NCT00003636Phase 3Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Sep 1998
- Primary completion
- Jan 2009
- Modality
- DNA Intercalators/Alkylators
- Countries
- 15
01
Overview
A Phase 3 trial of cisplatin, carboplatin in ovarian epithelial carcinoma, primary peritoneal carcinoma (PPC), fallopian tube carcinoma (PFTC), sponsored by European Organisation for Research and Treatment of Cancer. Started Sep 1998; status: completed.
02
Drugs
cisplatincarboplatin
03
Conditions
ovarian epithelial carcinomaprimary peritoneal carcinoma (PPC)fallopian tube carcinoma (PFTC)
Beyond the preview
Go deeper on NCT00003636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003636.